UBC The current public health crisis has accelerated collecting data in a decentralized manner. The biopharmacuetical industry had already begun to harness transformative approaches to collecting data in novel ways, including from remote sources across a wide range of settings...

UBC SAN DIEGO and BLUE BELL, Pa., Feb. 3, 2022 /PRNewswire/ — UBC, a late-stage research and patient support services organization has partnered with Seqster PDM, Inc. (“Seqster”), the leading patient-centric healthcare technology company, to provide nationwide health record interoperability...

H1 With the H1: Trial Landscape, our clients can leverage unique clinical insights for data driven decision-making, easily segmenting and analysing patient populations, to facilitate more diversity and inclusion in clinical trials.

H1 Gone are the days when Conferences & Pubs defined the KOL landscape. Social media has transformed thought leadership, and if you’re not engaging Digital Opinion Leaders, then your teams will be a step behind some of the most meaningful...

H1 Our client, a top 25 Global Pharma company, needed to better understand the top global key opinion leaders in pulmonary disease and oncology. They also needed to identify related second and third level rising stars to ensure continued adoption...

H1 Our client was planning a launch of a product within a new indication. To ensure they were targeting the right audience, they wanted to better understand the treatment landscape across a total of five indications. H1 delivered the top...

H1 has worked with the top Pharmaceuticals and Life Sciences Companies to help them better understand the HCP Universe. Specifically, H1 clients were seeking to increase MSL engagement. In reviewing the work done across those organizations, H1 uncovered an interesting...

LABCORP Mobile Clinical Services (MCS) uses a patient-centric approach to transforming clinical trials, allowing for a suite of clinical trial visit services to be conducted at any time, wherever the patient may be by using a centrally managed network of...

LABCORP Traditionally, clinical trials follow a standardized format, whereby the participant in the trial must attend the clinical site or sites for the purposes of screening, enrollment, treatment administration and data collection. However, the rigid structure of a conventional clinical...

LABCORP OncologyThere is a gap between the number of patients needed to participate in new cancer trials and the number who give consent to take part. Decentralized clinical trials (DCTs) are helping to address this gap by increasing the reach...